Internal Server Error

Johnson & Johnson - About the company

Johnson & Johnson is a public company based in New Brunswick (United States), founded in 1886 by Edward Mead Johnson and Tyler Rochwerg. It operates as a Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products. Johnson & Johnson has raised an undisclosed amount in funding. The company has 1444 active competitors, including 87 funded and 185 that have exited. Its top competitors include companies like AbbVie, Gilead and Amgen.

Company Details

Manufacturer, developer, and supplier of beauty care products, medical devices, and pharmaceutical products. The company working in medical devices are 3-D printing artificial joints personalized for each patient, while researchers in pharmaceuticals use AI to discover lifesaving drugs. It also pride on fostering healthy supplier relationships that are built on trust, transparency and unparalleled innovation, quality and reliability with an extended supply base comprising about 50,000 suppliers across our three business segments. In 2022, the company recorded annual revenues of $96.31B and a net profit of $12.72B.
Social
XFacebook
Email ID
*****@its.jnj.com
Registered Address
Higi House, L.B.S. Marg, Mulund West, Mumbai, Mumbai, Mumbai, Maharashtra, India, 400080
Key Metrics
Founded Year
1886
Location
New Brunswick, United States
Stage
Public
Ranked
Annual Revenue
$1B+ as on Dec 31, 2025
Employee Count
133,830 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public

Johnson & Johnson's IPO details

Johnson & Johnson got listed on Jan 06, 1978.
Click here to take a look at Johnson & Johnson's IPO in detail
Sign up to download Johnson & Johnson's company profile

Johnson & Johnson's funding and investors

Johnson & Johnson has raised funding over 4 rounds. Its first funding round was on Aug 02, 2011. Johnson & Johnson has 18 institutional investors.

Here is the list of recent funding rounds of Johnson & Johnson:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Feb 20, 2025
9667247
Conventional Debt
8526974
1961255
6147330
3350802
May 01, 2023
7903657
Grant (prize money)
8828463
7474572
2247626
Nov 05, 2018
4206424
Post IPO
7447026
4660149
5812666
lockAccess funding benchmarks and valuations. Sign up today!

Johnson & Johnson's founders and board of directors

Founder? Claim Profile
The founders of Johnson & Johnson are Edward Mead Johnson and Tyler Rochwerg. Joaquin Duato is the CEO of Johnson & Johnson.
Here are the details of Johnson & Johnson's key team members:

Johnson & Johnson's employee count trend

Johnson & Johnson has 133,830 employees as of Sep 26. Here is Johnson & Johnson's employee count trend over the years:
Employee count trend for Johnson & Johnson
lockUncover Johnson & Johnson's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Johnson & Johnson's Competitors and alternates

Top competitors of Johnson & Johnson include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Johnson & Johnson, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for AbbVie
AbbVie
2012, Chicago (United States), Public
Research-based biopharmaceutical company
$14.7B
83/100
2nd
Logo for Gilead
Gilead
1987, Foster City (United States), Acquired
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
-
81/100
3rd
Logo for Amgen
Amgen
1980, Thousand Oaks (United States), Public
Developer of pharmaceutical products for treating multiple diseases
-
79/100
4th
Logo for AstraZeneca
AstraZeneca
1999, Cambridge (United Kingdom), Public
Developer of pharmaceutical medicines for oncology and various chronic diseases
-
76/100
5th
Logo for Lilly
Lilly
1876, Indianapolis (United States), Public
Developer of traditional pharmaceutical medicines
-
75/100
6th
Logo for Johnson & Johnson
Johnson & Johnson
1886, New Brunswick (United States), Public
Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products
-
76/100
7th
Logo for Roivant Sciences
Roivant Sciences
2014, New York City (United States), Public
Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases
$1.3B
71/100
8th
Logo for Novartis
Novartis
1996, Basel (Switzerland), Acquired
R&D focused on manufacturing of drugs for multiple therapeutic areas
-
71/100
9th
Logo for Roche
Roche
1896, Basel (Switzerland), Public
Developer of pharmaceuticals and diagnostics kits
-
70/100
10th
Logo for Genentech
Genentech
1976, San Francisco (United States), Acquired
R&D company focused on manufacturing drugs for multiple therapeutic areas
$72.5M
68/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Johnson & Johnson's competitors? Click here to see the top ones

Johnson & Johnson's Investments and acquisitions

Johnson & Johnson has made 38 investments in companies including Tempo Therapeutics and SonoThera. Johnson & Johnson has also acquired 59 companies including Firefly Bio and Atraverse Medical.
Here is the list of investments & acquisitions:lockFilter this list
Date of Investment/Acquisition
Type
Company Name
Founded Year
Location
Sep 18, 2026
Investments
2014
San Diego (United States)
Jun 08, 2026
Investments
2022
San Francisco (United States)
Jun 08, 2026
Acquisition
2022
San Francisco (United States)
lockWant to know more about where corporates are investing? Sign up today!
See all investments and acquisitions by Johnson & Johnson

Reports related to Johnson & Johnson

Here is the latest report on Johnson & Johnson's sector:

News related to Johnson & Johnson

lockFilter this list
Media has covered Johnson & Johnson for a total of 398 events in the last 1 year, 244 of them have been about company updates and 13 about partnerships.
•
Dawson returns to CJFHC as CEO after tenure at Johnson & JohnsonBee Star•Oct 09, 2026•Johnson & Johnson
•
CHMP backs expanded use of teclistamabPharmaTimes•Sep 22, 2026•Johnson & Johnson
•
J&J's Caplyta Shows Positive Results in Bipolar I Disorder Trialhttps://www.clinicaltrialsarena.com/•Sep 22, 2026•Johnson & Johnson
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Johnson & Johnson

Explore our recently published companies
  • Superflash - Unfunded company
  • Swapter - Kyiv based, 2022 founded, Unfunded company
  • SvetRating - Palo Alto based, 2018 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford